logo
Lioncroft Wholesale CEO: 'Technology drives us forward, but let's not forget the risks'

Lioncroft Wholesale CEO: 'Technology drives us forward, but let's not forget the risks'

Independent4 hours ago

We all recognise the many, many ways technology enables us to innovate and scale. Virtually every UK business relies upon the latest technologies to keep the wheels of industry turning. Technology is how we manage our systems, process orders, handle data, support our people and communicate with the outside world. Technology is the very backbone of our business, leaving us woefully unprepared for if, and when, things go wrong.
And go wrong they have, in recent weeks. It has been impossible to miss the news headlines screaming loud about cyber attacks which have wreaked havoc on UK household names such as M&S, the Co-op and Harrods, to name just three.
M&S was first struck in April, and as we go to press in June, the business is still in recovery mode with a return to normal not expected until July. Their once-full shelves are now dotted with availability gaps – the ultimate nightmare for a retailer – while their previously booming online sales were brought to an abrupt halt as the company's systems were hacked and disabled. As if this weren't enough, M&S must also brace itself for class action data lawsuits after private data, including millions of customers' household information, telephone numbers and dates of birth, was leaked as a result of the attack.
The impact financially is staggering. The losses to the British high street stalwart look set to be unprecedented – Bank of America Global Research predicted the losses to equate to £43m per week, and estimated to run to more than £400m in total – acting as a harsh wake-up call for every business to think more about the technology it relies upon. And this is without taking into consideration the reputational damage an incident like this can cause.
The PR spin about technology – always on, always working – has made it a business essential. After all, technology never has an off day, it doesn't make mistakes. It doesn't get ill, tired or burnout. It doesn't get distracted from the task at hand by an unscheduled meeting or an unexpected phone call. It completes the task efficiently and accurately, and moves on to the next. Until it doesn't.
So how can it go wrong? Stuart Machin, CEO of M&S, described the security breach as the result of 'social engineering' which came about from 'human error' via a 'third party' although this has yet to be confirmed by the company's internal investigation. In other words, we are the weakest link. We open emails, click on links, share passwords, leave laptops on trains… the list goes on. While it is people that operate the technology, there will always be risks, it is unavoidable.
As M&S continue to repair, the smart businesses will now be using this incident as a learning exercise. Every business, regardless of size and sector, is a potential target, so what can we learn from this? Are we protected? How would we respond? These are the questions we must ask ourselves.
The fact is, when it comes to cyber protection, the work is never done. A constant stream of new threats are defeated by even newer solutions, and protecting your business goes far beyond strong passwords and the latest virus protection. The experts all agree that businesses need multi-layers of protection to secure their systems, combined with insurance.
Are you thinking ahead? We're told that M&S had carried out a cyber attack simulation the previous year and could tap into the learnings from this, responding quickly and effectively. Its business continuity plan kicked in, minimising further damage.
Yes, cyber insurance is essential, but as many business owners have found, it is costly, complex and limited with what it will deliver. Explore the options carefully and with caution.
While we focus on our systems, of course we must also focus on our people. It is our responsibility to equip staff with the knowledge they need to recognise threats and the tactics used by cyberhackers to ensure your business has a culture of security awareness.
There is no doubt that technology is our friend, but let's never forget that it can quickly turn to work against us, as well as for us.
Dr Jason Wouhra OBE is CEO of Lioncroft Wholesale, one of the UK's leading food and drink wholesalers. He is also Chancellor of Aston University and Chair of Unitas Wholesale, the UK's largest wholesale buying group.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GSK to slash cost of malaria jab by more than half
GSK to slash cost of malaria jab by more than half

Telegraph

time25 minutes ago

  • Telegraph

GSK to slash cost of malaria jab by more than half

The manufacturers of the world's first malaria vaccine are set to slash the price by more than half by 2028 to less than £4 per dose. On Wednesday the manufacturers of the shot, known as RTS,S, said a phased reduction in cost would begin immediately, with an ultimate aim to reduce the price to less than $5 (£3.64). The announcement could hardly come at a more critical moment. Gavi, a major vaccination initiative which funds immunisations in the world's poorest countries, is facing a major budget crunch. In Brussels on Wednesday, Gavi's replenishment event raised $9 billion (£6.55bn) to fund immunisation programmes over the next five years. While this sounds like a huge sum, it's significantly less than the $11.9bn the group had been aiming for. Governments around the world are cutting development spending dramatically. The UK, for instance, cut its contribution to Gavi by 40 per cent in real terms, telling The Telegraph it was prioritising defence, while the US has pledged nothing at all. Though America previously gave Gavi roughly $300m a year, the country's new health secretary claimed without evidence that the organisation was ignoring vaccine safety. The announcement from the British pharmaceutical giant GSK and Indian drugmaker Bharat Biotech will therefore be a relief to those trying to balance the books. Closing the gap between supply and need In a statement the companies said the price reduction demonstrated their 'commitment to Gavi', and was 'driven by process improvements, expanded production capacity, cost-effective manufacturing, and minimal profit margins'. By the time the price has fallen to below $5 per dose, a technology transfer agreement means Bharat will have taken over production, though GSK will continue to supply the adjuvant piece of the shot. 'For us, this is more than a cooperation, it's a promise,' said Dr Krishna Ella, Executive Chairman of Bharat Biotech International Limited. 'By joining forces with GSK, and working closely with Gavi, and the WHO [World Health Organization], we are taking a real step toward closing the gap between vaccine supply and the urgent needs of children at risk of malaria.' Each year, malaria still kills 500,000 people – the vast majority of them children aged five and under in sub-Saharan Africa. According to WHO estimates, cases and deaths fell significantly between 2000 and 2015, but progress has since stalled. Some have high hopes that RTS,S, as well as another vaccine called R21 developed by Oxford University, could prove critical in efforts to turn the tide. In clinical trials, RTS,S reduced hospitalisations for severe malaria by 30 per cent. But critics say the shot is too expensive and not as effective as existing tools, such as bed nets and antimalarials. The reduction in price will bring it more in line with the cost of R21, which is priced at around $4 per dose (roughly £3). Yet the cost will still add up, as both jabs require multiple shots. For RTS,S, this means four doses – the first three doses are given monthly, starting around five months of age, while the fourth dose is administered 15-18 months later. Both jabs 'provide reasonable short term efficacy – over about a year – so are a useful addition to other measures,' said Professor Nick White, a professor at the Mahidol-Oxford Tropical Medicine Research Unit who specialises in malaria. 'In the past GSK had limited production capacity – one of the reasons the R21 was developed. So reducing the price will be good and the two comparable vaccines can fight it out in the market place.' A spokesperson for Gavi said the alliance's goal is to 'create sustainable demand backed by predictable financing so that companies – like GSK and Bharat – can continue investing in technology transfer and other efficiencies that bring down costs, thus making critical vaccines more available and affordable. GSK's decision to lower its prices, the spokesperson added, is 'an important step for the global malaria vaccination programme, and our ability to make this lifesaving tool more widely available to those who need it the most'. Gavi plans to help fund RTS,S in 12 African countries by the end of this year. Previously, GSK has said it will supply up to 18 million vaccine doses between 2023 and the end of this year. The company plans to supply 15 million doses annually from 2026-2028, a spokesperson told Reuters.

Security fears force council to remove iPads from schools
Security fears force council to remove iPads from schools

BBC News

time38 minutes ago

  • BBC News

Security fears force council to remove iPads from schools

More than 2,000 iPads are to be removed from school classrooms in Argyll & Bute to avoid the devices becoming a security risk.A report for the local council stated the devices must be taken out of use by October 2026 before they develop "critical security vulnerabilities".Just under 1,000 devices have already been removed this year because of software being out of date and no longer compatible with Apple's security releases. Councillors agreed to provide more than £1.5m of funding over a five year period to expand the existing computer rolling replacement programme (CRRP) to also include iPads and Chrome books. CRRP previously did not cover iPads or Chrome books, meaning there was no funding available to replace iPads when they became director Douglas Hendry said: " Due to a lack of current device replacement strategies at school level, schools can face challenges when outdated equipment, which can no longer be supported, is removed from the network due to becoming obsolete or posing a security risk to the network."In April 2025, the ICT security team advised of the immediate removal of 970 iPads running Apple iPad software below version 17 from the school network due to critical security vulnerabilities."Another 399 iPads are to be removed by October 2025, with a further 904 needing replaced by October Hatton, an analyst with the firm CCS Insight, said the speed of change with modern technology could create regular issues for told BBC Scotland News: "This is certainly a concern in some areas of tech. If we look at laptops, for example, the imminent end of life for laptops running Windows 10 will cause major problems for many organizations yet to upgrade to hardware capable of running Windows 11. "We would expect quite a few cybersecurity concerns to arise over the coming years, for organizations and consumers, if people don't upgrade their devices."Councillor Audrey Forrest, policy lead for education with the local authority, said the CRRP expansion would "ensure that our children and young people have the best possible learning opportunities and gain essential knowledge and skills to help them thrive."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store